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introduction
Genomics holds great promise to improve human health. 
Genetics of common disorders (diabetes, cancer, cardiovas-
cular diseases) and monogenic subtypes (maturity-onset dia-
betes of the young, BRCA1/2, familial hypercholesterolemia, 
and long QT syndrome), in particular, are expected to come 
increasingly to the forefront in primary care. Consequently, 
general practitioners (GPs) are facing a daunting informational 
challenge to keep abreast of the expanding body of genom-
ics knowledge and attain competencies for informed use of 
its potential for personalized patient care.1 In view of increas-
ing requests for DNA-based predictive testing arising from a 
positive family history and GPs’ increasing involvement in pre-
ventive checkups, it is important for GPs to be competent to 
take and interpret a family history and deal appropriately with 
patients’ questions and concerns.2 Each family practice has a 
substantial number of unidentified asymptomatic patients with 
relatively young first-degree relatives with familial or heredi-
tary forms of cancer (breast, ovarian, uterine, and colorectal 
cancer), and such patients should be referred to a clinical genet-
icist for counseling and/or screening according to guidelines.3,4 
Women carrying a BRCA1/2 mutation, for example, have a life-
time risk of 60–80% of developing breast cancer (accounting 
for 5–10% of all breast cancer cases), and timely identification 
enables them to benefit from otherwise unexploited life-saving 
“risk-management options,” such as salpingo-oophorectomy 
and/or mastectomy, annual screening, and pharmaceutical 
chemopreventive options.5 Assessing familial risk by taking a 
family history can be a reliable method to improve outcomes 
of hereditary forms of cancer with targeted cancer prevention 
strategies.6–9 Taking an adequate family history, however, is 
difficult and time consuming. Insufficient genetics knowledge 
and consultation skills to actually conduct an initial oncoge-
netics risk assessment and its interpretation pose a barrier to 
appropriately recognize and elicit details to assess the features 
of potential oncogenetic risks.6 This could warrant timely 
referral to oncogenetics services for further assessment and 
genetic testing (referral-level competences). Moreover, lack of 
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computerized decision support implies that GPs themselves 
need to learn how to adequately interpret family history and 
act on it.10 Educational innovation therefore seems imperative, 
including genetic risk ascertainment and prevention.11 Unless 
GPs receive proper education and training, individual genetic 
care by GPs will likely be unhelpful and possibly even harm-
ful.3,12,13 Considering the urgent need for and the potentially 
huge benefits to be gained from genetics education for GPs, we 
embarked on an educational project aimed at strengthening the 
role of genetics in family medicine.
Well-defined core genetics competencies for nongenetic 
health-care workers are considered a precondition for the 
development of effective genetics education.14,15 Educational 
activities should be responsive to GPs’ assessed needs with 
respect to cognitive (knowledge), psychomotor (consultation 
skills), and affective (attitude) aspects of genetics compe-
tence. Previous studies have shown that as far as genetics is 
concerned, nongenetic health-care workers require not only 
education but also clear guidelines and definitions of their 
responsibilities.16,17
This article reports a study in which GPs attended a needs-
based, interactive oncogenetics training aimed at enhancing 
their insight, consultation skills, and attitudes relevant to the 
identification of oncogenetic disease in family practice consul-
tations. We evaluated the effects of the training in two ways: 
(i) office visits by standardized patients (SPs) to determine the 
extent to which GPs synthesized and applied the newly learned 
behaviors and (ii) questionnaires to determine GPs’ satisfaction 
with the training and perceived applicability of the new genetics 
consultation skills in their practice.
MAtEriALs And MEtHods
Experimental design
We conducted a pragmatic, blinded, randomized controlled 
trial (RCT) with parallel repeated measurements using a 
performance checklist and questionnaires. Kirkpatrick’s 
four-level framework for evaluating educational outcomes 
entails (i) valuation (satisfaction), (ii) learning (knowledge 
and knowledge retention), (iii) behavior (applying knowl-
edge about timely identification of patients at risk and 
referral), and (iv) effects on patient health and organization 
(change in practice and results).18,19 The design included an 
innovative measurement method with office visits by SPs 
aimed at the third level. Unannounced SP visits are a proven 
method to collect data about real practice in a direct and 
reliable way.20
Participating GPs were randomly assigned to a training date: 
December/January for the intervention group (four sessions) or 
March/April for the control group (three sessions). The trial ran 
from December 2011 to April 2012.
The RCT involved an intervention (oncogenetics train-
ing) and repeated measurements before the intervention 
(T0), 1 month after the intervention (T1), and 3 months (T2) 
after the intervention (Table 1). All participants completed a 
demographics survey at T0. Between T0 and T1, the interven-
tion group attended the training, whereas the control group 
received no intervention. For the evaluation of genetic consul-
tation and of consultation skills at T0 (pretest), T1 (posttest), 
and T2 (retention test), SPs were asked to complete checklists 
after consultations with both GP groups (level 4).21 The SPs were 
blinded to the GPs’ group assignment. To measure satisfaction 
with the training (level 1), the intervention group completed 
a questionnaire at T1. To measure the participants’ perceived 
applicability of the training content (level x), the intervention 
group answered a questionnaire at T2. To stimulate compliance 
of control group participants, they were invited to attend the 
training after T2.
The ethical review boards of the Netherlands Association for 
Medical Education, Maastricht University Medical Center, and 
VU University Medical Center, Amsterdam, The Netherlands, 
approved the study protocol. All participants gave written 
informed consent before the trial.
Participants
The project team collaborated with the Dutch College of 
General Practitioners (NHG) and local training providers to 
recruit GPs working full or part time in general practice.
For logistic reasons, recruitment was limited to all GPs prac-
ticing in two Dutch provinces, who received an invitational 
online mailing with information about the aim of the study, the 
table 1 Timetable of the randomized controlled trial showing scheduled measurement times, instruments, and 
 measurements made (indicated with X) in the intervention and control groups
instrument Group
time
0
2 Weeks
1 Month 3 Months
Pretest (t0) Posttest (t1)
retention test 
(t2)
Standardized patients’ checklist Intervention X Oncogenetics 
training
X X
Control X X X
Satisfaction questionnaire Intervention X
Applicability questionnaire Intervention X
Demographics questionnaire Intervention and control X
Measurement made with the instrument indicated in column 1, in the group indicated in column 2.
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contents of the face-to-face training, and the evaluation proce-
dure. Accreditation points were offered to GPs completing the 
study. A book on genetics in general practice or a book voucher 
of equal value was offered as an extra incentive. Four e-mail or 
telephone reminders were sent to nonresponders.
Eighty participants were needed to detect a medium to large 
sized effect with a power of 90% and significance level of 5%.22 
Figure 1 shows the randomization scheme and participation.
intervention
The intervention group attended a 4-h face-to-face evening 
training covering oncogenetic consultation skills (family his-
tory, familial risk assessment, and efficient referral), attitude 
(medical ethical issues), and clinical knowledge required in pri-
mary-care genetic consultations. More specifically, the training 
comprised the following educational content aimed at equip-
ping GPs to:
•	 Recall	clinically	relevant	information	about	types	of	hered-
itary	cancer	(breast,	ovarian,	colon,	skin),	including	genes	
associated	with	oncogenetics	syndromes	most	commonly	
tested	for;
•	 Recognize patients with features suggesting inherited pre-
disposition to cancer;
•	 Draw a family tree as a tool to identify patients at risk;
•	 Discuss (possible) familial and hereditary cancer risks, 
management of potentially developing hereditary cancer 
(i.e., surveillance and risk-reducing surgical options), and 
related ethical issues;
•	 Identify patients for referral for risk assessment and find 
relevant information online using oncogenetics guidelines;
•	 Explain the possibilities and limitations of oncogenetic test-
ing; and
•	 Know	when	to	consult	and/or	refer	to	a	genetics	specialist.
The training was developed by a multidisciplinary team 
consisting of an NHG educational expert (L.E.J.v.d.J.), a GP 
researcher (E.J.F.H.), two clinical geneticists, and two educa-
tionalists (S.J.v.L and C.v.d.V.). The focus was on oncogenetic 
diseases with relatively high prevalence in family practice 
(breast cancer due to BRCA mutations, colon cancer (e.g., 
familial adenomatous polyposis, Lynch syndrome) due to APC/
mismatch–repair gene mutations, and skin cancer (e.g., familial 
atypical multiple mole melanoma syndrome due to CDKN2A 
Figure 1 consort diagram of randomization and participation.
88 GPs randomized
Email invitation sent to 2,100
general practitioners (GPs)
practicing in the Netherlands
2,012 Non-responders
42 GPs allocated to control group:
1 Did not participate
22 No valid 1st standardized patient checklist
19 Completed 1st standardized patient checklist
46 GPs allocated to intervention group:
3 Did not participate
3 No valid 1st standardized patient checklist
40 Completed 1st standardized patient checklist
40 Attended workshop (intervention)
38 Completed 2nd standardized patient checklist
38 Completed 3rd standardized patient checklist
38 GPs × 3 standardized patient checklists analyzed 18 GPs × 3 standardized patient checklists analyzed
17 Completed online applicability questionnaire
2 Lost to follow-up
18 Completed 2nd standardized patient checklist
18 Completed 3rd standardized patient checklist
1 Lost to follow-up
18 Completed online satisfaction questionnaire
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(p16) gene mutations)). The training started with a 1-h inter-
active theoretical session on hereditary forms of cancer led by 
a clinical geneticist from a local academic hospital who was 
familiar with the aims of the program, followed by a 1-h session 
with two patients of the Dutch BRCA patient organization, who 
talked about their experiences, discussed ethical issues, and 
answered questions. A short break was followed by a 2-h work-
shop in which participants in small groups engaged in three 
role-playing consultations for three oncogenetic problems in 
the presence of experts (clinical geneticist, patient representa-
tives, and two trainers). Patients and GPs were role-played by 
participants, and the others gave feedback.
Measurements
Standardized patients. For a detailed description of the training 
sessions with SPs preceding the practice visits, clinical case 
scenarios, and development and finalization of the checklist, 
see Supplementary Tables S1 and S2 online; Supplementary 
Materials and Methods online.23
Questionnaires. Three online self-reported questionnaires 
were used to collect data on satisfaction, applicability of 
new consultation skills, and demographics and practice 
characteristics (see Supplementary Tables S3, S4, and S5 
online). The instruments were developed and validated in 
collaboration with the research team. The questionnaires 
were developed and validated in collaboration with content 
experts (experts in daily clinical genetics, a GP, and an expert 
in education and questionnaire development) and pilot 
tested.
The satisfaction questionnaire contained two items with five-
point Likert scales (1: completely disagree; 5: completely agree) 
(In the questionnaires, the coding was directed oppositely 
(1: completely agree, 5: completely disagree) in accordance with 
the conventions of the NHG. For ease of interpretation, in the 
current article, the ratings were recoded to comply with inter-
national conventions (1: completely disagree, 5: completely 
agree).) and an item with a global rating on a 10-point scale. 
The applicability questionnaire contained six items with five-
point Likert scales and one item with a four-point ordinal scale.
regression analysis
For a detailed description of regression analysis to investigate 
improvement of genetic consultation behavioral skills, see 
Supplementary Materials and Methods online.
Satisfaction with the intervention and applicability scores 
was analyzed by calculating the mean scores, 95% confidence 
intervals, and SDs for the pooled data from the satisfaction 
questionnaire. All analyses were performed using SPSS version 
19 (SPSS, Chicago, IL).
rEsuLts
randomization and dropout comparisons
Of 88 randomized GPs who agreed to participate in the train-
ing in December/January 2011/2012 (intervention group) or 
March/April 2012 (control group), 56 (38 intervention, 18 con-
trol group) completed the entire procedure, and 32 were lost to 
follow-up due to lack of time or sickness (Figure 1).
Participant characteristics
Participants in the intervention and control groups did not dif-
fer significantly in age, sex, years of experience, type of office, or 
office situation (Supplementary Table S6 online).
Effects of the intervention on oncogenetics-related learned 
consultation skills
Each of the 56 family physicians was visited by three SPs, por-
traying different cases, resulting in 168 first visits (Figure 1).
Figure 2 shows the raw mean performance scores (propor-
tion correct) for the control and intervention groups at times 
T0 (pretest), T1 (posttest), and T2 (retention test). Between-
group differences were found to be nonsignificant for the 
pretest and retention test, but the posttest difference of 0.19 
in favor of the intervention group was found to be significant 
(t-test; P < 0.0005). These estimations, however, are based on 
raw means and may be biased due to differences in difficulty 
between the three SP cases. More precise and unbiased estima-
tions were obtained by the regression analysis (Table 2). The 
regression results for the T1 score showed that the effect of the 
intervention (the coefficient for training) was statistically sig-
nificant and amounted to 0.14 on the proportion-correct scale; 
the corresponding value for the standardized regression coef-
ficient was equal to 0.34, indicating a moderate effect size. The 
analysis for the T2 score showed that the significant interven-
tion effect persisted until the retention measurement at T2 (2 
months later) and amounted to 0.11 (standardized regression 
coefficient = 0.28, moderate effect size). Hence, the perfor-
mance improvement due to the intervention was still substan-
tial at T2, being equal to 80% of the immediate effect at T1.
Effect modification of the treatment effect by baseline value 
was tested for the T1 and T2 scores; for both variables, the effect 
modification was found to be nonsignificant.
satisfaction and applicability
The satisfaction questionnaire resulted in high scores for the 
two items (both 4.4) and a global score of 7.7; when applica-
bility is also considered, favorable scores were found for all six 
items (3.5–4.5). Overall, 65% of the trainees reported applying 
the newly learned skills monthly, and 35% weekly (Table 3).
discussion
summary of main findings
To our knowledge, this is the first RCT to use SPs to investigate 
improvement of GPs’ oncogenetic professional behavior after 
attendance of an oncogenetics training. The results show sus-
tained improvement 3 months after the training, as well as high 
satisfaction with the training and positive perceptions of the 
practical applicability of the training topics.
Immediate and long-term training effects were evaluated at 
Kirkpatrick’s level 3 (behavior showing evidence of learning), 
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which enhances the value of the findings.22,24 The results indicate 
that case-based oncogenetics education can achieve sustained 
improvement with a moderate effect size in urgently desired 
genetics competencies for GPs, whereas the positive results 
for satisfaction and applicability may reflect a move toward a 
culture of genetic medical practice improvement. Educational 
interventions likely have a small-to-moderate effect on physi-
cian knowledge and performance, and patient outcomes.25 A 
few factors that were applied could have supported this result, 
such as active and interactive sessions, and single-group and 
smaller-group sessions. Whether there is a sustainable impact 
on applicability of the training in practice, including timely 
identification of patients with a possible cancer predisposition 
syndrome and appropriate referral, will need further longer-
term studies. Designed to fill gaps in physicians’ competencies 
and boost their confidence in using basic clinical genetic prin-
ciples and activities,26–30 the oncogenetics training addressed 
previously prioritized key features of genetic consultation skills 
and attitude but not basic science knowledge.
In previous studies, SPs have been used successfully to assess 
changes in clinical competence and performance and sustained 
effectiveness of behavioral training31,32 but not to evaluate atti-
tudinal factors cited as directing practice performance, such as 
patient satisfaction.21
After the training, the participating GPs seemed to be more 
comfortable incorporating oncogenetics aspects into patient 
consultation skills, as reflected in their high perceived appli-
cability. It seems plausible that this, in turn, will enhance effi-
cient and effective referral for genetic counseling. Whether the 
latter effect will materialize, however, remains to be examined 
in future studies. Taylor et al.33 discussed barriers to effective 
primary-care involvement in the expanding field of adult genet-
ics, arguing that genetic medicine should be part of integrated 
medical care and therefore of primary-care medicine. We agree 
with this viewpoint and feel that the training we designed 
shows promise to enhance communication between GPs and 
the genetics community, identification of high-risk patients, 
and timely referral to genetics services.
Methodological considerations
One of the aims of including real patients and simulated con-
sultations in our training was to promote a favorable attitude 
among GPs toward the application of genetic competencies. A 
study by Carroll et al.34 measured intent to use clinical genetics 
scenarios and increase competence due to a multifaceted knowl-
edge translation intervention but used questionnaires and not 
ratings of observed practice behaviors. Patient and societal per-
spectives on legal consequences of DNA-based testing results 
(e.g., being able to find a genetics information source or ability 
to obtain a mortgage or life insurance), however, demand that 
physicians’ effective use of genetics be demonstrated by actual 
performance in health-care practice.7,21 We therefore deliber-
ately deployed trained and blinded SPs to optimize the value 
of the measurement. Repeated SP visits may have impacted the 
outcome of learning effects in both study groups, because the 
Figure 2 Performance scores for oncogenetics consultation skills as 
measured by proportion correct on sP checklists (mean and 95% 
confidence interval) for control group (black) and intervention group 
(gray) at t0, t1, and t2, corresponding to pretest, posttest, and 
retention test measurements, respectively. SP, standardized patient.
Performance score oncogenetics skills
Pretest (T0) Posttest (T1) Retention test (T2)
Pr
op
or
tio
n 
co
rre
ct
0.0
0.2
0.4
0.6
0.8
1.0
Control 
Intervention 
P = 0.74 P < 0.0005 P = 0.33
table 2 Effect of the oncogenetics training on the performance of GPs
dependent 
variable independent variables
constant score t0 training
regression 
coefficient regression coefficient
standardized 
regression 
coefficient regression coefficient
standardized 
regression 
coefficient
Value 95% ci Value Value 95% ci Value
Low High Low High
T1 score 0.58c 0.23 −0.02 0.47 0.23  0.14b 0.05 0.23 0.34
T2 score 0.52c 0.15 −0.07 0.38 0.16  0.11a 0.03 0.20 0.28
Regression results are shown for immediate gain of performance (T1 score) and retention of performance (T2 score), using the pretest score (T0 score) as a covariate and 
the control group score as a reference.
CI, confidence interval; GP, general practitioner.
aP < 0.05; bP < 0.01; cP < 0.001.
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GPs would have had a higher level of awareness of being cri-
tiqued and could have felt a certain pressure to perform appro-
priately, but this is controlled for in the current study thanks to 
its RCT design.35
Rollnick et al.26 suggested that learner-directed and context-
bound consultation skills training should be integrated into 
everyday practice in a way that is acceptable to clinicians. On 
the basis of this principle, we had physicians identify their train-
ing needs and tailored our training to the practice context by 
patient-centered consultation skills training. On the basis of the 
results of our earlier studies, we emphasized everyday genetic 
clinical experiences more than consultation skills and atti-
tude alone.16,17 Our strategy could therefore be described as an 
“enriched context-bound consultation skills training.” Informal 
comments after the training by participants made clear that this 
format had a positive effect on their learning.
Potential oncogenetic problems are considered very personal 
topics to discuss between a patient and their GP.16 This is why it 
was not discussed in an incognito setting with a so-called “new” 
patient or unannounced, concealed simulated patient.27
strengths and limitations
A strength of the study was measuring change in consultation 
skills after the training by using SPs in particular, as opposed to 
using computerized case-based testing, for example. A varia-
tion of measurement instruments was proposed to predict 
practice performance.28 SP-based measurement is relatively 
unobtrusive, highly authentic, and based on patient perception. 
Another strength of the study is the fact that the educational 
intervention was tailored to the learners’ needs.6,16 Because the 
current study is confined to one health-care setting within one 
country, the generalizability of the results may be limited. The 
training’s demands on resources, facilities, and logistics may 
limit the feasibility of training delivery in many different set-
tings. Nevertheless, SP-based assessment is a valid instrument 
to describe what happens in real practice and can therefore pro-
vide valuable information for advanced development of genetic 
trainings. The study design introduces the possibility of bias by 
virtue of each GP seeing three different case presentations in 
different orders. This potential limitation was acknowledged, 
and statistical accommodations were made.
Using comparable case scenarios in this study, it was pos-
sible to measure change in checklist scores over time. However, 
it remains to be investigated whether it is possible to use dif-
ferent scenarios, for example, based upon on a family history 
alone. This would be a scenario seen in daily GP practice and 
the time when timely referral could be of benefit to the pres-
ymptomatic patient in regards to preventing or reducing famil-
ial cancer risk. Future studies could include assessing the issues 
addressed in the study by Culver et al.,29 namely, satisfaction 
with the time to address concerns, acknowledgments of patient 
concerns about cancer risk by physician, and offering reassur-
ance. Using the validated checklist, the current study measured 
GPs’ genetics consultation skills, thereby reflecting that train-
ing outcomes’ covering the full scope of good practice consulta-
tions: key ingredients related to family history taking, genetic 
table 3 Satisfaction (intervention only; n = 18) and self-reported applicability (intervention only; n = 17) as a result of 
oncogenetics training
Variable Mean (min–max)
95% ci
sdLow High
Satisfaction
 Would recommend the module to a colleaguea 4.4 (2–5) 3.9 4.9 0.98
 Content of the module is relevant for a GP 4.4 (1–5) 3.8 5.0 1.10
 Content of the knowledge test is relevant for a GP 4.1 (2–5) 3.7 4.5 0.83
 Global score (1–10) 7.7 (1–10) 6.7 8.6 1.90
Applicability
 Recognize patient with genetic disease sooner 4.1 (2–5) 3.6 4.5 0.90
 Sooner refer to or discuss with a genetic specialist 3.9 (3–5) 3.5 4.4 0.77
 More knowledge of possibilities/limitations of genetic tests 4.0 (3–5) 3.7 4.3 0.61
 More knowledge of genetic diseases 3.7 (1–5) 3.2 4.2 1.00
 More knowledge of basic genetic concepts 3.5 (2–5) 3.2 3.9 0.72
 More knowledge of genetic information sources 4.5 (2–5) 4.0 4.9 0.87
Proportion of trainees applying the learned knowledge %
 Daily  0
 Weekly 35
 Monthly 65
 Not (do not encounter any genetic problems in our practice)  0
CI, confidence interval; GP, general practitioner; max, maximum; min, minimum.
aIf not indicated otherwise, results refer to scores of five-point Likert scale items (1: completely disagree; 5: completely agree).
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risk assessment, and referral to genetics specialists. The SPs 
requested standard 10-min appointments. This may seem short 
for a first consultation; however, this is a standard duration in 
the Netherlands. If requested, in “real-world” clinical practice, 
a follow-up appointment could be made to adequately address 
all the concerned issues . However, in the study design, the SPs 
came in with a concern possibly related to an inherited form of 
cancer. The extent to which GPs synthesized and applied the 
newly learned behaviors was assessed by long-term changes in 
a 28-item checklist score, not by whether all issues would be 
discussed. Performance assessment is considered representa-
tive of a product of competence, influences of individual (e.g., 
health, relationships), and organization (e.g., facilities, practice 
time). GPs were therefore similarly assessed for performance 
under equivalent conditions (e.g., appointment time limitation 
focused entirely on the sole reason for the visit, without distrac-
tion or delay).21,30,32
Although the 3-month study period may have been too short 
to detect sustainable practice improvement in the long term, 
repeated measurement of consultation skills predicts practice 
performance in the long term.21,31
Voluntary participation by interested GPs could have caused 
selection bias. However, similarity of the baseline characteristics 
of the two groups and comparability of the 60% participation 
rate with that of other studies among GPs36,37 indicate that the 
participants were representative of GPs likely to attend onco-
genetic training in the future. Furthermore, it is possible that 
participating in the oncogenetics training might become part of 
standard training for all GPs. There was an imbalance however 
between  the dropout rate in the intervention and control group 
and the reason for this is not clear. Attending the training in the 
beginning of the trial period could have provided the urgent 
information to be able to satisfactorily finish all measurements 
long-term. Participants in the control group on the other hand 
had to wait for training content, possibly causing resistance 
to finish all measurements resulting in dropout. General rea-
sons for dropout were reported (no time and sickness) but not 
specific attributes. It is therefore unlikely that self-selection in 
dropout negatively impacted the validity of the results.
A pragmatic and blinded study design has known limitations.38 
Obviously, it is preferable for an RCT in which participants are 
blinded to inclusion in the intervention or control group, and 
those conducting the measurements are blinded as well.39 We 
achieved this by blinding the SPs to the GPs’ group allocation 
and by having two independent researchers (A.M.M.M. and 
S.R.v.T.) analyze the checklist scores in a blinded manner.
The results indicate that an oncogenetics training designed 
to meet GPs’ educational needs can be a satisfactory and fea-
sible method for sustained improvement of competencies to 
ensure appropriate application in family medicine of devel-
opments from the rapidly evolving field of genetics. Learner-
directed and context-bound genetics education appears to be 
a valuable tool to stimulate GPs to deliver genetic services.40 
We plan to use the results to inform the design of new train-
ings on complex genetic diseases, including hereditary forms of 
cancer, cardiovascular disease, and diabetes, in our continuing 
efforts to improve referral strategies and timely recognition of 
high-risk genetic patients. Large-scale international RCTs with 
adequate power are warranted to further assess how genetics 
education can improve health care.
SUPPLEMENTARY MATERIAL
Supplementary material is linked to the online version of the paper 
at http://www.nature.com/gim
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